t cell repertoire
Showing 1 - 25 of >10,000
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- (no location specified)
Sep 13, 2023
Circulating Tumor DNA and T Cell Repertoire Predict
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Brain Metastases
- Whole-brain radiotherapy
-
Wuhan, Hubei, ChinaUnion hospital
Feb 12, 2023
B- and T-cell Repertoire and Immune Response in Acute and
Recruiting
- COVID-19
-
Washington, District of Columbia
- +3 more
Jan 24, 2023
ALLoreactive T-Cell receptOr RePertoire in kidnEy
Recruiting
- Renal Transplant Rejection
- +3 more
- Mixed lymphocyte reaction
-
Vienna, AustriaMedical university of Vienna
Apr 5, 2022
T-cell Repertoire in Acute Myeloid Leukemia Undergoing Donor
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 16, 2021
T and B Cell Repertoire Changes in Response to Orencia® in
Recruiting
- Rheumatoid Arthritis
-
New York, New YorkHospital for Special Surgery
Mar 13, 2023
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Completed
- Psoriasis
- Mycosis Fungoides
-
Sacramento, CaliforniaUniversity of California, Davis Department of Dermatology
Mar 3, 2021
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,
Recruiting
- Metastatic Breast Cancer
- +2 more
- Abemaciclib
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jun 7, 2022
COVID, SARS-CoV 2, Corona Virus Infection Trial in Antwerp
Recruiting
- COVID
- +4 more
-
Antwerp, BelgiumUniversitairy hospital of Antwerp
Apr 4, 2022
Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer Trial in Paris (Saliva sampling, Blood sampling, Interviews)
Not yet recruiting
- Venous Ulcer
- +3 more
- Saliva sampling
- +3 more
-
Paris, Ile De France, FranceDermatology unit - Cochin Hospital - APHP
Sep 8, 2023
Will Permit Sites to Proactively Assess TAA, HLA and HPV-16
Terminated
- Head and Neck Cancer
- +7 more
- Tumor Profiling
-
Scottsdale, Arizona
- +2 more
Dec 2, 2022
Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)
Recruiting
- Extranodal NK T Cell Lymphoma
- NK-Cell Leukemia
- Anti-CD56 CAR T
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023
T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023
Celiac Disease Trial in Boston (Gluten Powder)
Recruiting
- Celiac Disease
- Gluten Powder
-
Boston, MassachusettsCeliac Research Centre Mass General Hospital
Jul 1, 2022
T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail
Recruiting
- T-cell Lymphoma
- +30 more
- Optional Blood Sample
- Optional Nail Sample
-
Duarte, California
- +25 more
Jul 28, 2023
Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)
Not yet recruiting
- Peripheral T Cell Lymphoma
- CAR-T Therapy
-
Hefei, Anhui, China
- +7 more
Jul 31, 2023
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CD19/CD22-bispecific CAR-T cells
-
Beijing, Beijing, ChinaLiang Wang
Oct 7, 2023
Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)
Recruiting
- Cutaneous T-cell Lymphoma
- Linperlisib in combined with Chidamide
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 8, 2023
T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)
Not yet recruiting
- T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
- CD7-CART01
- (no location specified)
Sep 26, 2023
ASCT Versus Chemotherapy as First-Line Consolidation Therapy
Completed
- T-cell Lymphoma Adults
- consolidation with ASCT
- (no location specified)
Nov 25, 2023
Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma Trial in Xiamen (Chidamide combined
Recruiting
- Peripheral T Cell Lymphoma
- +2 more
- Chidamide combined with Duvillisib
-
Xiamen, Fujian, ChinaThe First Affiliated Hosptial of Xiamen University
Nov 28, 2023
CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study
Not yet recruiting
- Lymphoma
- Chimeric Antigen Receptor
- (no location specified)
Oct 24, 2023
T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)
Recruiting
- T-Cell Acute Lymphocytic Leukemia
- CD7 CAR-T
-
Langfang, Hebei, ChinaHebei Yanda Hospital
Jun 26, 2023
T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)
Not yet recruiting
- T Cell Lymphoma
- Mogamulizumab
- DA-EPOCH Protocol
-
New Haven, ConnecticutYale Smilow Cancer Hospital
Aug 14, 2023
T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)
Not yet recruiting
- T-Cell Non-Hodgkin Lymphoma
- +14 more
- WU-CART-007
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023